首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Correction: Al-Zamel N. et al. A Dual GLP-1/GIP Receptor agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019 20 3532

【2h】

Correction: Al-Zamel N. et al. A Dual GLP-1/GIP Receptor agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019 20 3532

机译：更正：Al-ZamelN.等。双重GLP-1 / GIP受体激动剂不会在其受体上拮抗胰高血糖素但可能会在GLP-1受体上充当偏向激动剂。诠释J.摩尔科学2019203532

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The author wishes to make the following correction to this paper [ ]. Due to mislabeling, replace:

机译：作者希望对本文进行以下更正[]。由于标签错误，请更换：

著录项

期刊名称 International Journal of Molecular Sciences
作者
Noura Al-Zamel; Suleiman Al-Sabah; Yunus Luqmani; Lobna Adi; Siby Chacko; Tom Dario Schneider; Cornelius Krasel;
展开▼
作者单位

展开▼
年(卷),期 2020(21),9
年度 2020
页码 -1
总页数 2
原文格式 PDF
正文语种
中图分类分子生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor. [J] . Coopman K, Huang Y, Johnston N, The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics . 2010,第3期

机译：内源性激动剂胰高血糖素样肽1（GLP-1）-（7-36）酰胺与小分子前变构剂“化合物2”在GLP-1受体上的比较作用。
2. A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice [J] . Victor Gault, Vikas Bhat, Nigel Irwin, The Journal of biological chemistry . 2013,第49期

机译：一种新的胰高血糖素类肽-1（GLP-1）/胰高血糖素杂化肽，其具有三效式激动剂活性，在葡萄糖依赖性胰岛素多肽，GLP-1和胰高血糖素受体以及高脂肪喂养小鼠的治疗潜力
3. Correction: Sato, K., et al. Identification of a Novel Oligosaccharide in Maple Syrup as a Potential Alternative Saccharide for Diabetes Mellitus Patients. Int. J. Mol. Sci. 2019, 20 , 5041 [J] . Kanta Sato, Noriaki Nagai, Tetsushi Yamamoto, International Journal of Molecular Sciences . 2020,第14期

机译：纠正：佐藤，K。等人。枫糖浆中新型寡糖的鉴定为糖尿病患者的潜在糖果。 int。 J.Mol。 SCI。 2019,20,5041
4. Discovery and Structural Optimization of High Affinity Co-Agonists at the Glucagon and GLP-1 Receptors [C] . Tao Ma, Jonathan Day, Vasily Gelfanov American Peptide Symposium . 2009

机译：胰高血糖素和GLP-1受体的高亲和力共激剂的发现与结构优化
5. Selective GLP-1 receptor antagonists and glucagon/GLP-1 co-agonists discovered through an investigation into the structure-activity relationship in glucagon-related peptides. [D] . Patterson, James T. 2011

机译：通过研究胰高血糖素相关肽的结构-活性关系，发现了选择性的GLP-1受体拮抗剂和胰高血糖素/ GLP-1共激动剂。
6. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor [O] . Noura Al-Zamel, Suleiman Al-Sabah, Yunus Luqmani, 2019

机译：双重GLP-1 / GIP受体激动剂不会拮抗胰高血糖素但可能会在GLP-1受体上充当偏向激动剂。
7. Correction: Marcuzzi, E., et al. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. Int. J. Mol. Sci. 2019, 20, 96 [O] . Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, 2019

机译：校正：Marcuzzi，E.等人。趋化因子和趋化因子受体：协调肿瘤转移。 int。 J.Mol。 SCI。 2019,20,96

Correction: Al-Zamel N. et al. A Dual GLP-1/GIP Receptor agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019 20 3532

摘要

著录项

相似文献

相关主题

期刊订阅